I'm less excited by the talk of £1,000,000 going on a epidemiological study. I don't find it exciting to know exactly how many people have the condition which I'm guessing is what they're going to look at. Especially as it's unlikely to be a very precise figure with all the biases that can be involved in sampling and the lack of a solid and widely used biomarker.
------
ME Association
1. Research into causation
All the basic running costs of the ME Biobank, which is part of the UCL Biobank at the Royal Free Hospital in London. The ME Biobank supplies blood samples and anonymised clinical data from people with ME/CFS to research groups in the UK and abroad. I chair the ME Biobank Steering Group
Post mortem research in collaboration with the Manchester Brain Bank - which can only proceed if people who want to donate to this type of research sign a Statement of Intent to do so
On going research into mitochondrial dysfunction and metabolomics at the University of Oxford, including a new PhD position in 2025
Funding to physios for ME, including a pilot study on lactate levels in people with ME/CFS - University of Liverpool - Professor Nicola Clague Baker et al
Under consideration - research into the underlying physiological cause of post exertion malaise
2. Research into diagnostic biomarkers - two separate studies
University of Surrey - Prof Robert Dorey
University of Oxford - Dr Karl Morten
3. Research into management and treatment
Management of dysautonomia - orthostatic intolerance and PoTS at University of Leeds - Prof Manoj Sivan
ME/CFS in pregnancy - University of Newcastle - Dr Emma Slack et al
Development of a clinical assessment toolkit for use in specialist referral services - University of Manchester - Prof Sarah Tyson et al
Clinical trial of a drug treatment - protocol agreed and contractual arrangements in progress
Preparation of academic paper on results from the Count ME in patient evidence survey - University of Essex
We are also discussing the possibility of funding a major new research study that will involve both Long Covid and ME/CFS and an epidemiological study - the total cost of which would be in excess of £1 million
Before making any further major funding decisions we want to see whether there are any major developments in cause and management of Long Covid that could be applied to ME/CFS. Sadly, despite pouring huge amounts of money into Long Covid there haven't been any breakthroughs relating to either cause or treatment so far
We also want to see whether there are any significant findings from the DeCodeME study that provide new ideas for research into biomarker development or causation
Further information on the research we are funding can be found on the MEA website news section and the Ramsay Research Fund section.
RRF website
https://meassociation.org.uk/ramsay-research/
The ME Biobank has a separate website
https://meassociation.org.uk/2024/12/end-of-year-updates-from-cure-me
Ends